Latest Bone density Stories
THOUSAND OAKS, Calif., Aug.
INDIANAPOLIS, Aug. 9, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data on EVISTAÂ® (raloxifene HCl tablets) therapy for more than three years was published online in Current Medical Research & Opinion.
FRAXÂ® is a computer-based algorithm developed by the World Health Organization Collaborating Centre for Metabolic Bone Diseases to help predict the 10-year risk of fragility fracture.
PHILADELPHIA, July 12, 2011 /PRNewswire/ -- Tarsa Therapeutics today reported progress in its two ongoing clinical development programs for its oral recombinant salmon calcitonin for the treatment and prevention of postmenopausal osteoporosis.
In Europe, a serious treatment gap is leaving millions of people at high risk of fragility fractures.
To fully optimize a drug therapy for osteoporosis and low bone mineral density (BMD), patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine (IOM).
A news study finds that the worse a woman's skin wrinkles are during the first few years of menopause, the lower her bone density is.
Patients with celiac disease are more than 4.5 times more likely to develop osteoporosis compared to healthy people in an age and gender matched cohort with no identifiable risk factors for osteoporosis.
- The act of sweetening by admixture of some saccharine substance.